300015 爱尔眼科
已收盘 07-22 15:00:00
资讯
新帖
简况
中欧医疗健康股票仓位升至三年最高 葛兰二季度十大重仓股出炉
澎湃新闻 · 07-19
中欧医疗健康股票仓位升至三年最高 葛兰二季度十大重仓股出炉
7月17日爱尔眼科现1946.73万元大宗交易
证券之星 · 07-17
7月17日爱尔眼科现1946.73万元大宗交易
7月12日爱尔眼科发生1笔大宗交易 成交金额1640.42万元
证券之星 · 07-12
7月12日爱尔眼科发生1笔大宗交易 成交金额1640.42万元
爱尔眼科涨10.24%，东吴证券二个月前给出“买入”评级
证券之星 · 07-11
爱尔眼科涨10.24%，东吴证券二个月前给出“买入”评级
爱尔眼科：1、截至2023年12月31日，公司境内医院256家，门诊部183家
证券之星 · 07-10
爱尔眼科：1、截至2023年12月31日，公司境内医院256家，门诊部183家
爱尔眼科：公司未收到相关信息，目前尚不了解具体原因，将积极与评级机构进行沟通
证券之星 · 07-08
爱尔眼科：公司未收到相关信息，目前尚不了解具体原因，将积极与评级机构进行沟通
【机构调研记录】睿远基金调研爱尔眼科
证券之星 · 07-05
【机构调研记录】睿远基金调研爱尔眼科
爱尔眼科：睿远基金投资者于7月3日调研我司
证券之星 · 07-04
爱尔眼科：睿远基金投资者于7月3日调研我司
爱尔眼科：您已于6月24日问过相似问题，请查阅此前回复内容和公司相关公告
证券之星 · 07-04
爱尔眼科：您已于6月24日问过相似问题，请查阅此前回复内容和公司相关公告
爱尔眼科(300015.SZ)累计回购1265.87万股 耗资2.18亿元
智通财经 · 07-01
爱尔眼科(300015.SZ)累计回购1265.87万股 耗资2.18亿元
爱尔眼科：二级市场股价受多方面因素影响，公司整体经营健康，发展稳步向好
证券之星 · 07-01
爱尔眼科：二级市场股价受多方面因素影响，公司整体经营健康，发展稳步向好
爱尔眼科：自2015年起爱尔眼科开启“海外之旅”以来，已先后布局中国香港、美国、欧洲和东南亚
证券之星 · 06-28
爱尔眼科：自2015年起爱尔眼科开启“海外之旅”以来，已先后布局中国香港、美国、欧洲和东南亚
爱尔眼科：公司在海外收购前考察的最主要的因素之一就是管理团队
证券之星 · 06-24
爱尔眼科：公司在海外收购前考察的最主要的因素之一就是管理团队
爱尔眼科：公司未参与转融通证券借出业务
证券之星 · 06-20
爱尔眼科：公司未参与转融通证券借出业务
【机构调研记录】泰信基金徐慕浩调研爱尔眼科
证券之星 · 06-20
【机构调研记录】泰信基金徐慕浩调研爱尔眼科
【机构调研记录】嘉实基金调研皖能电力、爱尔眼科
证券之星 · 06-20
【机构调研记录】嘉实基金调研皖能电力、爱尔眼科
爱尔眼科：对于近期的国采报量，公司认为，这将有利于公司未来白内障业务取得更大发展
证券之星 · 06-19
爱尔眼科：对于近期的国采报量，公司认为，这将有利于公司未来白内障业务取得更大发展
爱尔眼科：接受华泰证券等机构调研
每日经济新闻 · 06-19
爱尔眼科：接受华泰证券等机构调研
爱尔眼科：1、基于我国眼科医疗服务需求空间越来越大，公司将专注于眼科领域，致力于全眼科均衡协调发展
证券之星 · 06-19
爱尔眼科：1、基于我国眼科医疗服务需求空间越来越大，公司将专注于眼科领域，致力于全眼科均衡协调发展
爱尔眼科跌3.21% 某券商在其高点喊买入
中国经济网 · 06-19
爱尔眼科跌3.21% 某券商在其高点喊买入
加载更多
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":10.78,"timestamp":1721631831000,"preClose":10.8,"halted":0,"volume":64446461,"delay":0,"floatShares":7905000000,"shares":9327000000,"eps":0.3729,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.02,"latestTime":"07-22 15:00:00","open":10.8,"high":10.9,"low":10.68,"amount":696000000,"amplitude":0.0204,"askPrice":10.78,"askSize":2,"bidPrice":10.77,"bidSize":2193,"shortable":0,"etf":0,"ttmEps":0.3729,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"adjPreClose":10.8,"symbolType":"stock","openAndCloseTimeList":[[1721611800000,1721619000000],[1721624400000,1721631600000]],"highLimit":11.88,"lowLimit":9.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9327014495,"pbRate":5.12,"roa":"--","roe":"4.67%","epsLYR":0.3644,"committee":0.11715,"marketValue":100545000000,"floatMarketCap":85216000000,"peRate":28.908554,"changeRate":-0.0019,"turnoverRate":0.0082,"status":1},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2452423260","title":"中欧医疗健康股票仓位升至三年最高 葛兰二季度十大重仓股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2452423260","media":"澎湃新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452423260?lang=zh_cn&edition=full","pubTime":"2024-07-19 17:12","pubTimestamp":1721380320,"startTime":"0","endTime":"0","summary":" 中欧医疗健康股票仓位升至三年最高水平！7月19日，中欧基金葛兰在管的3只公募基金披露2024年二季报，其持仓情况也随之浮出水面。 截至2024年二季度末，葛兰在管公募基金规模约为407.65亿元，相较于一季度末时的458.74亿元，下降11.14%。 股票仓位方面，葛兰在2024年二季度小幅度提升了中欧医疗健康的股票仓位，由原本的92.79%升至93.73%，这已是该基金三年来最高水平；另外2只基金的股票仓位则小幅度下降。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2024-07-19/doc-inceshny5448585.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-07-19/doc-inceshny5448585.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999001093.SGD","09926","HK0000306701.USD","002371","605333","300308","300347","300502","000423","300759","600085","000921","603456","LU0320764599.SGD","LU0327786744.USD","LU0577902371.SGD","BK0187","600436","BK0028","600519","300760","LU1880383366.USD","LU1051769294.HKD","LU2148510915.USD","600276","LU0531971595.HKD","LU2488822045.USD","601127","603259","BK0236","LU0516423091.SGD","LU0871576103.HKD","HK0000306685.HKD","BK0171","IE00BMPRXN33.USD","IE00B543WZ88.USD","02273","000999","300015","600938","300274","LU1781817850.SGD","LU0880133367.SGD","000568","BK1219","LU0594300179.USD","002475","LU0359202008.SGD","LU0456827905.SGD","02269"],"gpt_icon":0},{"id":"2452187006","title":"7月17日爱尔眼科现1946.73万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2452187006","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452187006?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:40","pubTimestamp":1721205636,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日爱尔眼科发生大宗交易，交易数据如下：大宗交易成交价格10.58元，相对当日收盘价折价2.04%，成交184万股，成交金额1946.73万元，买方营业部为广发证券股份有限公司上海浦东新区东方路证券营业部，卖方营业部为华泰证券股份有限公司南京中山东路华泰证券大厦证券营业部。截至2024年7月17日收盘，爱尔眼科报收于10.8元，上涨2.47%，换手率1.56%，成交量123.28万手，成交额13.22亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700033669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0096","BK0077","BK0188","BK0196","BK0113","LU1146622755.USD","BK0114","BK0012","300015","LU1242518931.SGD","LU1242518857.USD","BK0200","LU1820825898.SGD","BK0236","LU0979878070.USD"],"gpt_icon":0},{"id":"2450614303","title":"7月12日爱尔眼科发生1笔大宗交易 成交金额1640.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450614303","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450614303?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:30","pubTimestamp":1720773032,"startTime":"0","endTime":"0","summary":"近三个月该股共发生19笔大宗交易，合计成交16.82万手，折价成交16笔。该股在过去半年内已有共计0.0股限售解禁股上市，占公司总股本的0.0%。截至2024年7月12日收盘，爱尔眼科报收于10.78元，下跌0.83%，换手率1.43%，成交量112.88万手，成交额12.17亿元。该股最近90天内共有25家机构给出评级，买入评级19家，增持评级5家，中性评级1家；过去90天内机构目标均价为16.82。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071200031788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","LU1242518857.USD","BK0012","LU1820825898.SGD","BK0188","LU0979878070.USD","BK0200","BK0077","BK0114","LU1242518931.SGD","300015","BK0028","BK0196","BK0113","BK0096","LU1146622755.USD"],"gpt_icon":0},{"id":"2450533898","title":"爱尔眼科涨10.24%，东吴证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2450533898","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450533898?lang=zh_cn&edition=full","pubTime":"2024-07-11 16:22","pubTimestamp":1720686174,"startTime":"0","endTime":"0","summary":"今日爱尔眼科涨10.24%，收盘报10.87元。2024年4月29日，东吴证券研究员朱国广,冉胜男发布了对爱尔眼科的研报《2023年报&2024一季报点评：高基数及宏观环境导致增长降速，Q1屈光保持增长》，该研报对爱尔眼科给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为81.15%。此外，华安证券研究员谭国超,陈珈蔚，国金证券研究员袁维近期也对该股发布了研报，同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100030223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300015"],"gpt_icon":0},{"id":"2450892277","title":"爱尔眼科：1、截至2023年12月31日，公司境内医院256家，门诊部183家","url":"https://stock-news.laohu8.com/highlight/detail?id=2450892277","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450892277?lang=zh_cn&edition=full","pubTime":"2024-07-10 21:01","pubTimestamp":1720616476,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科07月10日在投资者关系平台上答复投资者关心的问题。另外未来公司扩张战略偏重于国内还是海外并购，谢谢.爱尔眼科董秘：谢谢您对公司的关注。比如2023年年报固定资产中显示购置医疗设备5.30亿，处置或报废医疗设备2.27亿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071000045382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0188","BK0196","LU1820825898.SGD","LU0979878070.USD","BK0236","BK0012","LU1146622755.USD","BK0113","BK0077","BK0200","LU1242518931.SGD","300015","LU1242518857.USD","BK0114"],"gpt_icon":0},{"id":"2449704669","title":"爱尔眼科：公司未收到相关信息，目前尚不了解具体原因，将积极与评级机构进行沟通","url":"https://stock-news.laohu8.com/highlight/detail?id=2449704669","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449704669?lang=zh_cn&edition=full","pubTime":"2024-07-08 23:00","pubTimestamp":1720450833,"startTime":"0","endTime":"0","summary":"公司未收到相关信息，目前尚不了解具体原因，将积极与评级机构进行沟通。公司经营正常，无应发布而未发布的信息。公司密切关注洪涝的发展情况，目前影响不大。如有需要披露的信息，公司将按照信息披露要求发布公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070800032675.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2449312406","title":"【机构调研记录】睿远基金调研爱尔眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2449312406","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449312406?lang=zh_cn&edition=full","pubTime":"2024-07-05 08:02","pubTimestamp":1720137721,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月4日披露的机构调研信息，睿远基金近期对1家上市公司进行了调研，相关名单如下：1）爱尔眼科 个股亮点：公司全资子公司拉萨亮视创业投资有限公司投资设立湖南亮视长星医疗产业管理合伙企业；公司作为全国连锁的专业眼科医疗机构，主要从事各类眼科疾病诊疗、手术服务与医学验光配镜；公司与支付宝签订了战略合作协议,在服务窗、当面付、商圈生态建设、农村医疗市场开发等方面开展合作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500010242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1242518931.SGD","LU1146622755.USD","BK0113","BK0236","BK0077","LU0979878070.USD","LU1242518857.USD","BK0196","BK0200","BK0012","BK0188","BK0096","LU1820825898.SGD","BK0028","BK0114"],"gpt_icon":0},{"id":"2448424304","title":"爱尔眼科：睿远基金投资者于7月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2448424304","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448424304?lang=zh_cn&edition=full","pubTime":"2024-07-04 19:52","pubTimestamp":1720093953,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年7月4日爱尔眼科发布公告称睿远基金秦伟于2024年7月3日调研我司。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。爱尔眼科2024年一季报显示，公司主营收入51.96亿元，同比上升3.5%；归母净利润8.99亿元，同比上升15.16%；扣非净利润8.43亿元，同比上升12.04%；负债率32.28%，投资收益182.33万元，财务费用6194.39万元，毛利率48.29%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400038868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","LU1242518857.USD","LU1820825898.SGD","BK0196","BK0200","LU1146622755.USD","BK0236","LU0979878070.USD","300015","BK0188","BK0113","BK0077","BK0028","BK0114","LU1242518931.SGD","BK0012"],"gpt_icon":0},{"id":"2448144907","title":"爱尔眼科：您已于6月24日问过相似问题，请查阅此前回复内容和公司相关公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2448144907","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448144907?lang=zh_cn&edition=full","pubTime":"2024-07-04 19:01","pubTimestamp":1720090908,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科07月04日在投资者关系平台上答复投资者关心的问题。爱尔眼科董秘：您已于6月24日问过相似问题，请查阅此前回复内容和公司相关公告。投资者： 5月31日，爱尔眼科公告《关于收购重庆眼视光、周口爱尔等52家医疗机构部分股权的议案》共支付现金13.44亿元。2023年终，经审计这52家医疗机构所有者权益为负资不抵债且亏损医疗机构占比很大，共形成商誉11.98亿元，累计商誉77.63亿。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070400036416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","BK0028","BK0188","BK0196","LU1820825898.SGD","LU0979878070.USD","BK0236","BK0012","LU1146622755.USD","BK0113","BK0077","BK0200","LU1242518931.SGD","300015","LU1242518857.USD","BK0114"],"gpt_icon":0},{"id":"2448934169","title":"爱尔眼科(300015.SZ)累计回购1265.87万股 耗资2.18亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448934169","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448934169?lang=zh_cn&edition=full","pubTime":"2024-07-01 19:03","pubTimestamp":1719831833,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)公告，公司截至2024年6月30日以集中竞价交易方式回购公司股份1265.87万股，占公司总股本的比例为0.14%，成交总金额为2.18亿元(不含交易费用)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1143732.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1242518857.USD","LU1820825898.SGD","BK0236","BK0096","BK0196","BK0200","LU1146622755.USD","BK0012","LU1242518931.SGD","BK0113","LU0979878070.USD","BK0114","300015","BK0028","BK0188","BK0077"],"gpt_icon":0},{"id":"2448995967","title":"爱尔眼科：二级市场股价受多方面因素影响，公司整体经营健康，发展稳步向好","url":"https://stock-news.laohu8.com/highlight/detail?id=2448995967","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448995967?lang=zh_cn&edition=full","pubTime":"2024-07-01 18:03","pubTimestamp":1719828191,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科07月01日在投资者关系平台上答复投资者关心的问题。二级市场股价受多方面因素影响，公司整体经营健康，发展稳步向好。公司依据相关规定在定期报告中披露“持股5%以上股东、前10名股东及前10名无限售流通股股东参与转融通业务出借股份情况”，公司未参与转融通证券借出业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070100023421.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0236","LU0979878070.USD","BK0113","BK0077","BK0012","BK0188","BK0096","BK0114","LU1242518857.USD","300015","LU1820825898.SGD","BK0200","LU1242518931.SGD","LU1146622755.USD","BK0196"],"gpt_icon":0},{"id":"2446822508","title":"爱尔眼科：自2015年起爱尔眼科开启“海外之旅”以来，已先后布局中国香港、美国、欧洲和东南亚","url":"https://stock-news.laohu8.com/highlight/detail?id=2446822508","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446822508?lang=zh_cn&edition=full","pubTime":"2024-06-28 19:01","pubTimestamp":1719572495,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科06月28日在投资者关系平台上答复投资者关心的问题。自2015年起爱尔眼科开启“海外之旅”以来，已先后布局中国香港、美国、欧洲和东南亚。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062800044137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","BK0114","BK0196","BK0188","BK0200","LU0979878070.USD","LU1146622755.USD","LU1242518857.USD","LU1820825898.SGD","BK0096","BK0028","LU1242518931.SGD","BK0012","300015","BK0236","BK0077"],"gpt_icon":0},{"id":"2445292540","title":"爱尔眼科：公司在海外收购前考察的最主要的因素之一就是管理团队","url":"https://stock-news.laohu8.com/highlight/detail?id=2445292540","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445292540?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:02","pubTimestamp":1719223352,"startTime":"0","endTime":"0","summary":"公司在海外收购前考察的最主要的因素之一就是管理团队。在收购海外机构时保留现有管理团队并融合爱尔理念。投资者：5月31日，爱尔眼科公告《关于收购重庆眼视光、周口爱尔等52家医疗机构部分股权的议案》共支付现金13.44亿元。爱尔眼科董秘：公司对收购52家医疗机构的基本情况、收购的可行性与必要性进行了详尽披露，可在巨潮资讯网等指定信息披露渠道查阅。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400026214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","LU1242518857.USD","BK0012","LU1820825898.SGD","BK0188","LU0979878070.USD","BK0200","BK0077","BK0114","LU1242518931.SGD","300015","BK0028","BK0196","BK0113","BK0096","LU1146622755.USD"],"gpt_icon":0},{"id":"2444154292","title":"爱尔眼科：公司未参与转融通证券借出业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2444154292","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444154292?lang=zh_cn&edition=full","pubTime":"2024-06-20 19:01","pubTimestamp":1718881268,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科06月20日在投资者关系平台上答复投资者关心的问题。公司未参与转融通证券借出业务。2022年第四季度收入30.58亿，扣非后净利润4.152亿，2023年第四季同比增长41.25，扣非后净利润反而减少，为何？2023年第四季度，公司计提资产减值损失3.84亿元，对2023年第四季度扣非后净利润有所影响。详情请参阅公司定期报告。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000035386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","LU1242518931.SGD","LU1146622755.USD","BK0113","161629","BK0236","BK0077","LU0979878070.USD","LU1242518857.USD","BK0196","BK0200","BK0012","BK0188","BK0096","LU1820825898.SGD","BK0028","BK0114"],"gpt_icon":0},{"id":"2444752282","title":"【机构调研记录】泰信基金徐慕浩调研爱尔眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2444752282","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444752282?lang=zh_cn&edition=full","pubTime":"2024-06-20 08:01","pubTimestamp":1718841716,"startTime":"0","endTime":"0","summary":"；公司运动控制产品广泛应用于电子3C设备行业，例如：华为、OPPO/VIVO、比亚迪、富士康、小米等知名企业的智能化制造设备3）爱尔眼科 个股亮点：公司全资子公司拉萨亮视创业投资有限公司投资设立湖南亮视长星医疗产业管理合伙企业；公司作为全国连锁的专业眼科医疗机构，主要从事各类眼科疾病诊疗、手术服务与医学验光配镜；公司与支付宝签订了战略合作协议,在服务窗、当面付、商圈生态建设、农村医疗市场开发等方面开展合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000010803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","LU1820825898.SGD","BK0096","LU0979878070.USD","BK0012","LU1146622755.USD","BK0200","BK0196","BK0028","BK0114","BK0077","LU1242518857.USD","300015","LU1242518931.SGD","BK0236","BK0188"],"gpt_icon":0},{"id":"2444128224","title":"【机构调研记录】嘉实基金调研皖能电力、爱尔眼科","url":"https://stock-news.laohu8.com/highlight/detail?id=2444128224","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444128224?lang=zh_cn&edition=full","pubTime":"2024-06-20 08:01","pubTimestamp":1718841691,"startTime":"0","endTime":"0","summary":"嘉实基金成立于1999年，截至目前，资产管理规模9451.88亿元，排名7/204；资产管理规模5469.17亿元，排名8/204；管理公募基金数561只，排名8/204；旗下公募基金经理104人，排名2/204。旗下最近一年表现最佳的公募基金产品为嘉实全球产业升级股票发起式A，最新单位净值为1.65，近一年增长36.19%。旗下最新募集公募基金产品为嘉实价值丰裕混合A，类型为混合型-偏股，集中认购期2024年5月6日至2024年8月5日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062000010758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","LU1242518857.USD","BK0200","BK0012","BK0271","300015","BK0114","BK0196","BK0188","BK0028","LU1820825898.SGD","LU1146622755.USD","BK0113","BK0077","BK0096","LU1242518931.SGD","BK0143","BK0236","000543"],"gpt_icon":0},{"id":"2444473248","title":"爱尔眼科：对于近期的国采报量，公司认为，这将有利于公司未来白内障业务取得更大发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2444473248","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444473248?lang=zh_cn&edition=full","pubTime":"2024-06-19 20:00","pubTimestamp":1718798442,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科06月19日在投资者关系平台上答复投资者关心的问题。公司将医疗质量和服务水平放在第一位。在市场扩容、中高端产品逐步普及的情况下，公司医院技能覆盖面广、经验技术储备竞争力强，有信心未来取得更大发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900039565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0096","LU1242518857.USD","LU1820825898.SGD","BK0196","BK0200","LU1146622755.USD","BK0236","LU0979878070.USD","300015","BK0188","BK0113","BK0077","BK0028","BK0114","LU1242518931.SGD","BK0012"],"gpt_icon":0},{"id":"2444422417","title":"爱尔眼科：接受华泰证券等机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2444422417","media":"每日经济新闻","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444422417?lang=zh_cn&edition=full","pubTime":"2024-06-19 18:49","pubTimestamp":1718794166,"startTime":"0","endTime":"0","summary":"每经AI快讯，爱尔眼科 发布公告称，2024年6月18日，爱尔眼科接受华泰证券等机构调研，公司董事长陈邦、董事会秘书吴士君、董事会办公室工作人员参与接待，并回答了调研机构提出的问题。2023年1至12月份，爱尔眼科的营业收入构成为：医疗行业占比99.73%，其他业务收入占比0.27%。截至发稿，爱尔眼科市值为1040亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061918493795c187b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024061918493795c187b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601688","LU1328615791.USD","BK0183","06886","BK0077","BK0200","LU1242518857.USD","BK0012","LU1064131003.USD","LU1064130708.USD","LU1146622755.USD","LU1580142542.USD","BK0028","LU2148510915.USD","LU0979878070.USD","BK0188","BK0236","BK0114","BK0096","LU1242518931.SGD","BK0196","300015","LU1781817850.SGD","BK0276","BK0113","LU1820825898.SGD"],"gpt_icon":0},{"id":"2444423779","title":"爱尔眼科：1、基于我国眼科医疗服务需求空间越来越大，公司将专注于眼科领域，致力于全眼科均衡协调发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2444423779","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444423779?lang=zh_cn&edition=full","pubTime":"2024-06-19 17:01","pubTimestamp":1718787702,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科06月19日在投资者关系平台上答复投资者关心的问题。近期，公司欧洲子公司收购了英国眼科连锁机构Optimax，进军英国眼科市场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024061900034843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU0979878070.USD","LU1242518931.SGD","BK0096","BK0114","BK0077","BK0200","BK0012","BK0028","BK0113","LU1146622755.USD","BK0196","BK0236","LU1242518857.USD","LU1820825898.SGD","300015","BK0188"],"gpt_icon":0},{"id":"2444447243","title":"爱尔眼科跌3.21% 某券商在其高点喊买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2444447243","media":"中国经济网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2444447243?lang=zh_cn&edition=full","pubTime":"2024-06-19 16:05","pubTimestamp":1718784331,"startTime":"0","endTime":"0","summary":"中国经济网北京6月19日讯爱尔眼科(300015.SZ)股价今日收报11.15元，跌幅3.21%。2021年7月1日，爱尔眼科盘中达到上市以来最高点的72.27元。某券商2021年7月28日发布研报《爱尔眼科(300015)： ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun","url":"http://stock.10jqka.com.cn/hks/20240619/c658978709.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20240619/c658978709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["BK0188","BK0114","300015","LU1242518857.USD","BK0096","LU1146622755.USD","BK0077","BK0113","BK0196","BK0236","BK0012","LU1820825898.SGD","LU1242518931.SGD","LU0979878070.USD","BK0028","BK0200"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","stockEarnings":[{"period":"1week","weight":0.0286},{"period":"1month","weight":-0.0019},{"period":"3month","weight":-0.0965},{"period":"6month","weight":-0.2209},{"period":"1year","weight":-0.4507},{"period":"ytd","weight":-0.3101}],"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","perCapita":"23358股","boardName":"卫生","registeredCapital":"932701万元","compareEarnings":[{"period":"1week","weight":-0.0033},{"period":"1month","weight":-0.0113},{"period":"3month","weight":-0.0191},{"period":"6month","weight":0.0509},{"period":"1year","weight":-0.0642},{"period":"ytd","weight":-0.0036}],"survey":" 爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。","serverTime":1721674662108,"listedPrice":28,"stockholders":"338428人(较上一季度增加8.24%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}